Rosuvastatin reduces non–high-density lipoprotein cholesterol and lipoprotein remnants in patients with dysbetalipoproteinemia (Fredrickson type III hyperlipoproteinemia)
Blom, Dirk J., PhD, Marais, A. David, MD, Retterstøl, Kjetil, MD, Stein, Evan A., MD, Ycas, Joseph, PhD, Gu, Zheng, MD, Miller, Elinor, MD
Published in Journal of clinical lipidology (01.12.2008)
Published in Journal of clinical lipidology (01.12.2008)
Get full text
Journal Article